about
Management of HIV infection in patients with substance use problemsInteractions between atazanavir-ritonavir and tenofovir in heavily pretreated human immunodeficiency virus-infected patientsOnce-daily antiretroviral therapies for HIV infection: Consensus Statement of an Advisory Committee of the International Association of Physicians in AIDS Care.Prospective pilot study of a single daily dosage of trientine for the treatment of Wilson diseaseCorrelation between lamivudine plasma concentrations and patient self-reported adherence to antiretroviral treatment in experienced HIV patientsPlasma amprenavir pharmacokinetics and tolerability following administration of 1,400 milligrams of fosamprenavir once daily in combination with either 100 or 200 milligrams of ritonavir in healthy volunteersSimplification strategies to reduce antiretroviral drug exposure: progress and prospects.Guidelines for the use of extended-release nevirapine in HIV-infected patients.Electrocardiogram abnormalities with atazanavir and lopinavir/ritonavir.Pharmacokinetics of emtricitabine, didanosine and efavirenz administered once-daily for the treatment of HIV-infected adults (pharmacokinetic substudy of the ANRS 091 trial).
P2860
Q34113784-6474C9E8-893E-4E1C-BD56-46DF4E9D3038Q34141845-3C3BFD30-707D-438E-9173-E85EBFE04F2AQ35207299-8D617055-E08E-4357-90C0-DFCFFE2F4FC5Q35594074-9045E390-FD0A-4CFC-B3D9-7442B6F2FC1AQ35600417-FEA03536-8669-4C57-84AF-F7ED619DBCCBQ35636050-A7EAF6E7-637B-4724-9D47-91D3C4174814Q37277829-41380501-2337-49F6-BC63-02BE88D1FCE5Q37950493-D12C414D-40D6-455E-B83B-59FD52697018Q43244207-C2936061-0C03-4D6E-84D6-3E67A7025AD6Q44794032-17DE9698-4A87-489D-AC07-D052369F3C83
P2860
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Daily dosing of highly active antiretroviral therapy.
@en
Daily dosing of highly active antiretroviral therapy.
@nl
type
label
Daily dosing of highly active antiretroviral therapy.
@en
Daily dosing of highly active antiretroviral therapy.
@nl
prefLabel
Daily dosing of highly active antiretroviral therapy.
@en
Daily dosing of highly active antiretroviral therapy.
@nl
P2093
P356
P1476
Daily dosing of highly active antiretroviral therapy.
@en
P2093
Jeffrey P Nadler
Keith A Rosenbach
Robert Allison
P304
P356
10.1086/338255
P407
P577
2002-01-25T00:00:00Z